Should NVAX be acquired by a big pharma
Could Abbvie be a contender as a buyer? I know some suggest other companies but Abbvie has made two acquisitions in the last couple of weeks. That is of course if the crew at NVAX put it on the right course towards profitability and the pipeline is moving forward. Just curious. Probably not, I would assume, but they do have immunology involved in their company I believe. Pure speculation.